$7.29 (4.37%)

Volume: 401.217k

Closed: Dec 02, 2022

Hollow Logo Score: -0.705

Esperion Therapeutics Stock Forecast

$7.29 (4.37%)

Volume: 401.217k

Closed: Dec 02, 2022

Score Hollow Logo -0.705

Esperion Therapeutics Stock Statistics NASDAQ:ESPR

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-12-02 - 2022-12-02 HOLD 0
2022-11-14 - 2022-12-02 SELL -3.06
2022-10-07 - 2022-11-14 BUY 1.35
2022-09-29 - 2022-10-07 SELL 8.48
2022-09-28 - 2022-09-29 BUY -6.43

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE